Semiconductors
Compare Stocks
5 / 10Stock Comparison
ALAB vs MRVL vs CRUS vs MTSI vs ALGM
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Semiconductors
Semiconductors
Semiconductors
ALAB vs MRVL vs CRUS vs MTSI vs ALGM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Semiconductors | Semiconductors | Semiconductors | Semiconductors | Semiconductors |
| Market Cap | $33.30B | $138.57B | $8.76B | $25.84B | $8.88B |
| Revenue (TTM) | $1.00B | $8.19B | $2.00B | $1.07B | $840M |
| Net Income (TTM) | $268M | $2.67B | $414M | $177M | $-13M |
| Gross Margin | 76.0% | 51.0% | 52.8% | 55.3% | 45.0% |
| Operating Margin | 22.4% | 16.1% | 23.0% | 16.0% | -0.0% |
| Forward P/E | 78.4x | 41.7x | 18.9x | 76.9x | 90.2x |
| Total Debt | $35M | $4.47B | $134M | $538M | $368M |
| Cash & Equiv. | $168M | $2.64B | $801M | $112M | $121M |
ALAB vs MRVL vs CRUS vs MTSI vs ALGM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 24 | May 26 | Return |
|---|---|---|---|
| Astera Labs, Inc. C… (ALAB) | 100 | 263.7 | +163.7% |
| Marvell Technology,… (MRVL) | 100 | 225.8 | +125.8% |
| Cirrus Logic, Inc. (CRUS) | 100 | 185.5 | +85.5% |
| MACOM Technology So… (MTSI) | 100 | 360.2 | +260.2% |
| Allegro MicroSystem… (ALGM) | 100 | 177.8 | +77.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ALAB vs MRVL vs CRUS vs MTSI vs ALGM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ALAB has the current edge in this matchup, primarily because of its strength in growth exposure.
- Rev growth 115.1%, EPS growth 290.6%, 3Y rev CAGR 120.2%
- 115.1% revenue growth vs ALGM's -30.9%
- 18.3% ROA vs ALGM's -0.9%, ROIC 12.3% vs -1.3%
MRVL is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 15.8% 10Y total return vs MTSI's 8.0%
- 32.6% margin vs ALGM's -1.6%
- 0.1% yield; the other 4 pay no meaningful dividend
CRUS ranks third and is worth considering specifically for income & stability and sleep-well-at-night.
- Dividend streak 1 yrs, beta 1.12
- Lower volatility, beta 1.12, Low D/E 6.3%, current ratio 7.37x
- Beta 1.12, current ratio 7.37x
- Lower P/E (18.9x vs 90.2x)
MTSI is the clearest fit if your priority is momentum.
- +203.8% vs CRUS's +77.6%
Among these 5 stocks, ALGM doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 115.1% revenue growth vs ALGM's -30.9% | |
| Value | Lower P/E (18.9x vs 90.2x) | |
| Quality / Margins | 32.6% margin vs ALGM's -1.6% | |
| Stability / Safety | Beta 1.12 vs ALAB's 2.99 | |
| Dividends | 0.1% yield; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +203.8% vs CRUS's +77.6% | |
| Efficiency (ROA) | 18.3% ROA vs ALGM's -0.9%, ROIC 12.3% vs -1.3% |
ALAB vs MRVL vs CRUS vs MTSI vs ALGM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
ALAB vs MRVL vs CRUS vs MTSI vs ALGM — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CRUS leads in 2 of 6 categories
ALAB leads 1 • MTSI leads 1 • MRVL leads 0 • ALGM leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ALAB leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MRVL is the larger business by revenue, generating $8.2B annually — 9.8x ALGM's $840M. MRVL is the more profitable business, keeping 32.6% of every revenue dollar as net income compared to ALGM's -1.6%. On growth, ALAB holds the edge at +93.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.0B | $8.2B | $2.0B | $1.1B | $840M |
| EBITDAEarnings before interest/tax | $233M | $2.3B | $486M | $210M | $66M |
| Net IncomeAfter-tax profit | $268M | $2.7B | $414M | $177M | -$13M |
| Free Cash FlowCash after capex | $343M | $1.4B | $637M | $168M | $121M |
| Gross MarginGross profit ÷ Revenue | +76.0% | +51.0% | +52.8% | +55.3% | +45.0% |
| Operating MarginEBIT ÷ Revenue | +22.4% | +16.1% | +23.0% | +16.0% | -0.0% |
| Net MarginNet income ÷ Revenue | +26.7% | +32.6% | +20.7% | +16.5% | -1.6% |
| FCF MarginFCF ÷ Revenue | +34.2% | +17.0% | +31.9% | +15.6% | +14.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +93.4% | +22.1% | +5.7% | +22.5% | +28.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +144.4% | +100.0% | +19.1% | +42.9% | +2.2% |
Valuation Metrics
CRUS leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 21.9x trailing earnings, CRUS trades at a 86% valuation discount to ALAB's 160.4x P/E. On an enterprise value basis, CRUS's 16.6x EV/EBITDA is more attractive than ALGM's 204.2x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $33.3B | $138.6B | $8.8B | $25.8B | $8.9B |
| Enterprise ValueMkt cap + debt − cash | $33.2B | $140.4B | $8.1B | $26.3B | $9.1B |
| Trailing P/EPrice ÷ TTM EPS | 160.37x | 52.12x | 21.90x | -471.88x | -122.90x |
| Forward P/EPrice ÷ next-FY EPS est. | 78.43x | 41.72x | 18.94x | 76.91x | 90.21x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.31x | — | — |
| EV / EBITDAEnterprise value multiple | 184.02x | 106.14x | 16.64x | 136.13x | 204.21x |
| Price / SalesMarket cap ÷ Revenue | 39.06x | 16.91x | 4.38x | 26.71x | 12.25x |
| Price / BookPrice ÷ Book value/share | 25.76x | 9.73x | 4.22x | 19.20x | 9.66x |
| Price / FCFMarket cap ÷ FCF | 118.19x | 99.24x | 13.76x | 134.01x | 404.45x |
Profitability & Efficiency
CRUS leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
ALAB delivers a 20.3% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $-1 for ALGM. ALAB carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to MTSI's 0.41x. On the Piotroski fundamental quality scale (0–9), CRUS scores 8/9 vs ALGM's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +20.3% | +19.4% | +20.2% | +13.2% | -1.4% |
| ROA (TTM)Return on assets | +18.3% | +12.6% | +17.1% | +8.6% | -0.9% |
| ROICReturn on invested capital | +12.3% | +6.0% | +22.9% | +6.0% | -1.3% |
| ROCEReturn on capital employed | +14.7% | +7.1% | +20.8% | +7.6% | -1.5% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 | 8 | 5 | 3 |
| Debt / EquityFinancial leverage | 0.03x | 0.31x | 0.06x | 0.41x | 0.40x |
| Net DebtTotal debt minus cash | -$132M | $1.8B | -$667M | $426M | $247M |
| Cash & Equiv.Liquid assets | $168M | $2.6B | $801M | $112M | $121M |
| Total DebtShort + long-term debt | $35M | $4.5B | $134M | $538M | $368M |
| Interest CoverageEBIT ÷ Interest expense | — | 15.17x | 703.54x | 391.47x | -0.24x |
Total Returns (Dividends Reinvested)
MTSI leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MTSI five years ago would be worth $61,359 today (with dividends reinvested), compared to $19,334 for ALGM. Over the past 12 months, MTSI leads with a +203.8% total return vs CRUS's +77.6%. The 3-year compound annual growth rate (CAGR) favors MTSI at 84.4% vs ALGM's 8.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +9.0% | +79.1% | +43.5% | +96.9% | +78.1% |
| 1-Year ReturnPast 12 months | +175.2% | +184.6% | +77.6% | +203.8% | +156.4% |
| 3-Year ReturnCumulative with dividends | +215.4% | +291.9% | +120.0% | +526.9% | +27.4% |
| 5-Year ReturnCumulative with dividends | +215.4% | +250.8% | +124.1% | +513.6% | +93.3% |
| 10-Year ReturnCumulative with dividends | +215.4% | +1581.3% | +421.3% | +795.9% | +170.8% |
| CAGR (3Y)Annualised 3-year return | +46.7% | +57.7% | +30.1% | +84.4% | +8.4% |
Risk & Volatility
Evenly matched — CRUS and MTSI each lead in 1 of 2 comparable metrics.
Risk & Volatility
CRUS is the less volatile stock with a 1.12 beta — it tends to amplify market swings less than ALAB's 2.99 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MTSI currently trades 97.0% from its 52-week high vs ALAB's 74.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.99x | 2.21x | 1.12x | 1.75x | 2.43x |
| 52-Week HighHighest price in past year | $262.90 | $175.79 | $179.00 | $355.00 | $51.40 |
| 52-Week LowLowest price in past year | $63.40 | $53.78 | $91.32 | $110.09 | $18.17 |
| % of 52W HighCurrent price vs 52-week peak | +74.4% | +91.0% | +95.9% | +97.0% | +93.2% |
| RSI (14)Momentum oscillator 0–100 | 69.8 | 78.5 | 58.5 | 71.3 | 78.8 |
| Avg Volume (50D)Average daily shares traded | 5.1M | 24.8M | 600K | 1.1M | 1.9M |
Analyst Outlook
Evenly matched — CRUS and ALGM each lead in 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: ALAB as "Buy", MRVL as "Buy", CRUS as "Buy", MTSI as "Buy", ALGM as "Buy". Consensus price targets imply 2.8% upside for ALAB (target: $201) vs -26.3% for MTSI (target: $254). MRVL is the only dividend payer here at 0.15% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $201.13 | $129.52 | $145.00 | $254.00 | $44.83 |
| # AnalystsCovering analysts | 15 | 72 | 22 | 23 | 13 |
| Dividend YieldAnnual dividend ÷ price | — | +0.1% | — | — | — |
| Dividend StreakConsecutive years of raises | — | 0 | 1 | 0 | 1 |
| Dividend / ShareAnnual DPS | — | $0.24 | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.5% | +3.2% | +0.2% | +9.6% |
CRUS leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). ALAB leads in 1 (Income & Cash Flow). 2 tied.
ALAB vs MRVL vs CRUS vs MTSI vs ALGM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ALAB or MRVL or CRUS or MTSI or ALGM a better buy right now?
For growth investors, Astera Labs, Inc.
Common Stock (ALAB) is the stronger pick with 115. 1% revenue growth year-over-year, versus -30. 9% for Allegro MicroSystems, Inc. (ALGM). Cirrus Logic, Inc. (CRUS) offers the better valuation at 21. 9x trailing P/E (18. 9x forward), making it the more compelling value choice. Analysts rate Astera Labs, Inc. Common Stock (ALAB) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ALAB or MRVL or CRUS or MTSI or ALGM?
On trailing P/E, Cirrus Logic, Inc.
(CRUS) is the cheapest at 21. 9x versus Astera Labs, Inc. Common Stock at 160. 4x. On forward P/E, Cirrus Logic, Inc. is actually cheaper at 18. 9x.
03Which is the better long-term investment — ALAB or MRVL or CRUS or MTSI or ALGM?
Over the past 5 years, MACOM Technology Solutions Holdings, Inc.
(MTSI) delivered a total return of +513. 6%, compared to +93. 3% for Allegro MicroSystems, Inc. (ALGM). Over 10 years, the gap is even starker: MRVL returned +1581% versus ALGM's +170. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ALAB or MRVL or CRUS or MTSI or ALGM?
By beta (market sensitivity over 5 years), Cirrus Logic, Inc.
(CRUS) is the lower-risk stock at 1. 12β versus Astera Labs, Inc. Common Stock's 2. 99β — meaning ALAB is approximately 168% more volatile than CRUS relative to the S&P 500. On balance sheet safety, Astera Labs, Inc. Common Stock (ALAB) carries a lower debt/equity ratio of 3% versus 41% for MACOM Technology Solutions Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ALAB or MRVL or CRUS or MTSI or ALGM?
By revenue growth (latest reported year), Astera Labs, Inc.
Common Stock (ALAB) is pulling ahead at 115. 1% versus -30. 9% for Allegro MicroSystems, Inc. (ALGM). On earnings-per-share growth, the picture is similar: Marvell Technology, Inc. grew EPS 401. 0% year-over-year, compared to -170. 2% for MACOM Technology Solutions Holdings, Inc.. Over a 3-year CAGR, ALAB leads at 120. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ALAB or MRVL or CRUS or MTSI or ALGM?
Marvell Technology, Inc.
(MRVL) is the more profitable company, earning 32. 6% net margin versus -10. 1% for Allegro MicroSystems, Inc. — meaning it keeps 32. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CRUS leads at 23. 0% versus -2. 7% for ALGM. At the gross margin level — before operating expenses — ALAB leads at 75. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ALAB or MRVL or CRUS or MTSI or ALGM more undervalued right now?
On forward earnings alone, Cirrus Logic, Inc.
(CRUS) trades at 18. 9x forward P/E versus 90. 2x for Allegro MicroSystems, Inc. — 71. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ALAB: 2. 8% to $201. 13.
08Which pays a better dividend — ALAB or MRVL or CRUS or MTSI or ALGM?
In this comparison, MRVL (0.
1% yield) pays a dividend. ALAB, CRUS, MTSI, ALGM do not pay a meaningful dividend and should not be held primarily for income.
09Is ALAB or MRVL or CRUS or MTSI or ALGM better for a retirement portfolio?
For long-horizon retirement investors, Cirrus Logic, Inc.
(CRUS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 12), +421. 3% 10Y return). Allegro MicroSystems, Inc. (ALGM) carries a higher beta of 2. 43 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CRUS: +421. 3%, ALGM: +170. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ALAB and MRVL and CRUS and MTSI and ALGM?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: ALAB is a mid-cap high-growth stock; MRVL is a mid-cap high-growth stock; CRUS is a small-cap quality compounder stock; MTSI is a mid-cap high-growth stock; ALGM is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.